Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne

• Status: Completed
• Trial end date: 2008-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research study is to see how often benzoyl peroxide is applied for acne. Use of medication was monitored electronically.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wake Forest University
• Treatments: Benzoyl Peroxide

Criteria

Inclusion Criteria:

• Any male or female 13 to 18 years of age with a diagnosis of mild to moderate acne vulgaris by a dermatologist will be eligible for participation.

• Verbal consent of participation must be given by parent or guardian and child.

Exclusion Criteria:

• Age less than 13 or greater than 18 years of age.

• Known allergy or sensitivity to topical benzoyl peroxide gel in the subject.

• Inability to complete all study-related visits.

• Introduction of any other prescription medication, topical or systemic, for acne vulgaris while participating in the study.

• Subjects should not be using topical retinoids or benzoyl peroxide products, including Proactive® or topical prescription medications for the treatment of acne vulgaris for at least 2 weeks prior to beginning the study. Oral medications for the treatment of acne should not have been used at least 4 weeks prior to beginning the study.

• Women that are actively trying to become pregnant or wish to become pregnant during the time frame the study is to take place will be excluded.